US Open Surgery Instrument Market Size to Hit USD 1,456.16 Million by 2034

The US open surgery instrument market size was evaluated at USD 761.1 million in 2024 and is expected to grow around USD 1,456.16 million by 2034, registering a CAGR of 6.7% from 2025 to 2034.

The market for all types of open surgery instruments is growing in the U.S. due to the aging generation, chronic diseases, as well as because of modern technology, comprising enhancements in healthcare expenditure, infrastructure developments, increased surgical procedures, and ambulatory surgical centers coming into existence.

Highlights of the US Open Surgery Instrument Market

• By type insight, the catheter segment led the market in 2024.
• By type insight, the retractor segment is expected to grow at the fastest rate during the forecast period.

Industry Valuation and Growth Rate Projection

The U.S. open surgery instrument market is inclusive of tools utilized in traditional surgeries requiring large incisions. Such instruments are scalpels, forceps, retractors, and catheters. However, because of modern, minimally invasive techniques, some would see an eclipse of open surgery. Open surgeries can never be overshadowed because they are used in very complex procedures, and hence, there is always a demand for open surgical instruments in hospitals, surgical centers, and specialty clinics. Emerging technologies and changes to surgical styles are changing the open surgery instruments market in the U.S. Finally, the enhanced affinity of surgeons for minimally invasive techniques, including laparoscopic and robotic-assisted procedures, could somewhat diminish the demand for traditional instruments. On the opposite side, emergency and complex procedures imply the need for open surgery. Recent advances in surgical instruments, mainly direct energy instruments and closure instruments, provide an excellent opportunity to improve workflow efficiency and precision. An aging population and increasing healthcare spending, coupled with the development of infrastructure, create conditions for the steady growth of markets. Demand for high-performance and very expensive surgical instruments will continue to prevail as hospitals invest in modern equipment.

U.S. Open Surgery Instrument Market: Stats and Figures

• Among people living in households in the United States, 1 in 9 reported undergoing at least one surgical procedure in the past year.
• About 400,000 CABG procedures are performed annually in the U.S., with an estimated total cost of $16 billion.
• Approximately 950,000 PCIs are performed each year, costing an estimated $12 billion.

How AI Has Benefited the U.S. Open Surgery Instrument Market

AI is transforming the United States' open surgery instrument market by improving the aspects of dexterity, safety, and operative time. Through the analysis of real-time imaging, previous patient information, and anatomical structures, it can make surgeries more precise, thus preventing unnecessary damage to nearby tissues and increasing the success rate of surgery. Surgical efficiency is also improved with AI systems since they can automate certain redundant tasks, reduce overhead times, reduce physical fatigue, and increase patient throughput. Real-time alerts also lessen the possibilities of surgical errors.

AI contributes to individualized surgical planning by custom-fitting procedures based on patient variables, which leads to better results and recovery. AI simulations pertinent to surgery have provided the opportunity for launching surgical immersion learning environments for novice surgeons. Recovery classes of patients are monitored by algorithms, identification of early complications, and recommendation of optimized care pathways. The above, basically, are the benefits of modern surgery through which the standard for clinical treatment and patient care is being changed.

US Open Surgery Instrument Market Dynamics

What Are the Major Market Drivers in the U.S. Open Surgery Instrument Market?

The major market drivers in the U.S. open surgery instrument market are the growing geriatric population, the increasing prevalence of lifestyle-related diseases.

Growing geriatric population

In the U.S., the open surgery instrument market is primarily driven by the aging population, who are more vulnerable to degenerative health conditions like arthritis, cardiovascular diseases, and certain types of cancer. Open surgery is more complex concerning treatment, and thus older adults require more frequent hospitalizations and surgeries because of their weakened immune systems and slower recovery rates. The manufacturers have adjusted innovation toward fulfilling the peculiar needs of geriatric patients, such as ergonomic instruments for procedures that last longer and reducing instruments that cause tissue trauma.

Growing geriatric population

Lifestyle diseases like heart disease, obesity, and type 2 diabetes are posing a great demand for open surgical interventions. These conditions often develop into complications that call for invasive surgical procedures, thus making open surgery essential for performing complex or emergency cases. Direct energy and closure devices are some of the latest devices that are gaining a reputation for improving outcomes and enhancing control. With lifestyle diseases hitting the younger population harder, the open surgical instruments market is anticipated to experience good growth in the future.

What Are the Major Market Restraints in the U.S. Open Surgery Instrument Market?

The growth of the U.S. open surgery instrument market is restrained by factors such as high costs of advanced instruments, reimbursement challenges.

High costs of advanced instruments

In the U.S., the high price of modern surgical instruments is an impediment to the market for open surgery instruments. These include powered staplers, electrosurgical units, and

instruments for high-precision closure. These instruments may not be commercially viable for smaller healthcare institutions like rural hospitals and outpatient surgical centers, albeit offering some clinical advantages. A capital constraint would work against purchasing such high-value instruments. Operational liabilities, like maintenance, calibration, and training of staff, would also weigh heavily upon the procurement considerations. The high price, coupled with uncertain returns, has kept low-volume centers from investing in them, with a limited number of complex open surgical procedures. As such, the implementation of these high-end instruments in surgical procedures has remained in large metropolitan hospitals and academic medical centers, thus posing disparities in surgical care across various regions and types of facilities.

Reimbursement challenges

Inadequate reimbursement is a main stumbling block for the adoption of advanced open surgery instruments in the U.S. healthcare system. The vast majority of surgical procedures are reimbursed by bundled or fixed payments that truly do not consider the higher prices of premium surgical instruments. This misalignment between actual procedural costs and payer compensation may even cause financial losses, particularly with the more cost-intensive surgeries. There is generally a bias in reimbursement policies favoring MIS approaches, putting open surgery at a comparative disadvantage.

The absence of separate billing codes and explicit reimbursement incentives further dampens the attractiveness of the advanced surgical instruments. Hospitals may prefer standard and reusable instruments that are more cost-effective under this reimbursement method. Until payment policies change to take into account the clinical and operative value of the advanced surgical instruments, providers will remain hesitant to put money into these tools and thereby deprive patients of quality surgical care.

What Are the Market Opportunities in the U.S. Open Surgery Instrument Market?

The opportunities in the U.S. open surgery instrument market are associated with advanced technology,

The U.S. open surgery instrument market is experiencing a steady shift towards minimally invasive surgical (MIS) procedures, including laparoscopic and robotic-assisted surgeries; open surgeries retain their significance in cases where the processes are complex and in emergencies. Advanced surgical technologies like direct energy devices and advanced closure systems can enhance the precision and outcomes for patients in open procedures. Technological enhancements in surgical instrument design, such as lightweight materials and ergonomics, are sowing the seeds for innovations that have greater precision and fewer ergonomic considerations for the surgeon to weigh against muscle fatigue. A parallel road limiting reimbursement for robotic procedures while raising the demand for open surgeries may slow down MIS adoption, thus balancing the opportunity for the open surgery instrument marketplace.

Industry Leader Announcements

• Hani Abouhalka, company group chair, Surgery, Johnson & Johnson MedTech:

“Johnson & Johnson MedTech has been a trusted partner in surgery for over a century, and we are leveraging clinical insights to tailor the design of our technologies to meet the needs of surgeons and clinical teams. Dualto supports a more flexible and digitally connected OR ecosystem for the future of surgical care.”

• Darryl Rock, Vice President, Business Unit Leader, Surgical Solutions:

“Olympus has a proud legacy in medical technology, particularly as a pioneer in endoscopy. We are excited to partner with Ziosoft, which has its long history of developing AI software to help physicians make more accurate diagnostic and treatment decisions during procedures.”

Segmental Insights

By Type

Catheter segment dominated the market in 2024, owing to its pivotal role in various surgical procedures. Catheters have various applications, such as urinary drainage, drug administration, and fluid monitoring, to attend to the patient optimally during complicated procedures. They maintain bladder functions; either they prevent urinary retention or they meticulously monitor urinary output. In addition, they assist in hemorrhage control, chiefly in sites that are difficult to access. Catheters provide direct drug delivery into the bladder, wherein the bladder is either made accessible or protected during certain surgical procedures. For instance, ureteral catheters allow the ureters to be identified or protected during pelvic surgeries, while central venous catheters administer drugs or fluids or allow central venous pressure monitoring. The specters of infection, trauma, or thrombosis of the veins or arteries associated with catheters must be taken into account, thereby placing particular emphasis upon surgical selection, adequate staff training, and monitoring.

The retractor segment is expected to grow at the fastest CAGR during the forecast period. The retractor segment is forecasted to witness the fastest growth during the projected period in the U.S. open-surgery instrument market. In open surgical procedures, retractors are essential instruments for maintaining steady exposure with good visibility for operators. These retractors hold back organs, tissues, or muscle and thus keep the operative area clear of cluttering distractions, while Manual tissue handling is reduced, not to mention speeding up the whole procedure. The most important advantage of surgical retractors lies in visibility: good visualization of the area of interest allows surgeons to operate with greater precision and confidence. These instruments are observed in nearly every surgical specialty: general surgery, orthopedic procedures, urological and gynecologic surgeries, spinal surgeries, and tracheotomy. Mounting preference for advanced, ergonomic, and self-retaining retractors would likely keep fueling the demand in this segment.

Recent Developments in the U.S. Open Surgery Instrument Market:

• In June 2025, Arthrex, a global leader in minimally invasive surgical technology, launched the Synergy Power™ battery-powered system, suitable for various orthopedic applications. In April 2025, GEM Hospital launched a surgical instrument that enables surgeons to perform procedures with fewer instrument exchanges, blood loss, and minimal tissue damage.
• In March 2025, Johnson & Johnson MedTech launched its FDA-cleared Dualto energy system, a surgical solution that integrates multiple energy modalities for minimally invasive surgery, and plans to use it with its upcoming Ottava surgical robot.

Competitive Landscape

The market is moderately fragmented with local players like Stryker, Johnson & Johnson, and Medtronic, etc., wishing to take the time to edge their presence through investments, partnerships, acquisitions, and mergers. They also invest in product development and competitive pricing. These strategies will promote market growth and lucrative opportunities for market players

• Company Name: Medtronic
• Year of Incorporation: 1949
• Headquarters: Minneapolis, Minnesota, U.S.

In fiscal year 2025, Medtronic reported total revenue of $33.537 billion, with adjusted revenue of $33.627 billion. Medtronic acquired nano surface technology assets and IP rights related to Sites Medical's OsteoSync titanium pads for use in developing next-generation PEEK interbody fusion devices.

• Company Name: Johnson & Johnson
• Year of Incorporation: 1886
• Headquarters: New Brunswick, New Jersey, U.S.A

Johnson & Johnson's annual revenue for 2024 was $88.82 billion, a 4.3% increase from the $85.159 billion reported in 2023.

• Company Name: Stryker
• Year of Incorporation: 1941
• Headquarters: Kalamazoo, Michigan, USA

Stryker's most recent annual revenue for the year ending December 31, 2024, was $22.6 billion, a 10.2% increase compared to the previous year. Stryker has acquired Inari Medical, a company offering innovative VTE clot removal solutions, enhancing its peripheral vascular position in the rapidly growing VTE segment.